European Society of Toxicology In Vitro > News > ATLA Launching 4 special issues on NAMs!
1 April 2021

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on:

  • Biobanking – discuss the suitability of your MS with the VSC Editor Rita Seabra <rita@frame.org.uk>
  • In silico tools – discuss the suitability of your MS with the VSC Editor Judith Madden <J.C.Madden@ljmu.ac.uk>
  • Serum-free approaches – discuss the suitability of your MS with the VSC Editor Helena Kandarova <helena.kandarova@outlook.sk>
  • Educational resources – discuss thesuitability of your MS with the VSC Editor Esther Haugabrooks <EHaugabrooks@pcrm.org>

Articles will be made available online (subject to access rights) as soon as they are published.
• High visibility on the award-winning SAGE Journals platform, securing a wide international audience, including researchers, policymakers and educators.
• Prompt publishing and no submission or publication fees payable.

About the journal
ATLA is a peer-reviewed international journal that has been at the forefront of promoting and publishing on all aspects of the development, validation, implementation and use of animal alternatives, for almost 50 years. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out (the Three Rs).

Related content

The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research

To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.

ESTIV Corporate member’s event: EPISKIN ACADEMY Webinar

The second EPISKIN webinar is focusing on the theme eye irritation and Integrated Approaches to Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation for regulatory toxicology…

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding